Siemens Healthcare’s latest release of the ACUSON SC2000 volume imaging ultrasound system has received FDA 510(k) clearance, the company announced.
Siemens Healthcare’s latest release of the ACUSON SC2000 volume imaging ultrasound system has received FDA 510(k) clearance, the company announced.
The Release 2.0 of the company’s echocardiography system is now commercially available in the U.S., and is the first ultrasound system that enables production of real-time, full-volumetric cardiac images in one heart cycle, the company said.
New applications aimed at providing performance and imaging enhancements to improve workflow and patient outcomes include the quantification of the 3-D proximal isovelocity surface area (PISA) to assess the severity of valvular disease and volumetric color Doppler.
It also includes a comprehensive package for automated left ventricle analysis and Siemens’ IN Focus coherent image-forming technology, which processes information at 2.88 gigabytes per second, making it the fastest echocardiography system, according to the company. This allows users to focus on the entire field of view, revealing more detailed information in one image.
Release 2.0 supports volumetric intracardiac echocardiography, which enables the integration of the ACUSON AcuNav ultrasound catheters, the company said. Electrophysiologists and interventional cardiologists can obtain ultrasound images from within the heart in real time, the company said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.